Related references
Note: Only part of the references are listed.Moderate effect of artemisinin-based combination therapy on transmission of Plasmodium falciparum
JT Bousema et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Impact of HIV-associated immunosuppression on malaria infection and disease in Malawi
MK Laufer et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Effect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal, South Africa
KI Barnes et al.
PLOS MEDICINE (2005)
Combination therapy counteracts the enhanced transmission of drug-resistant malaria parasites to mosquitoes
RL Hallett et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Comparison of chlorproguanil-dapsone with sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in young African children: double-blind randomised controlled trial
A Alloueche et al.
LANCET (2004)
Short-course artesunate treatment of uncomplicated Plasmodium falciparum malaria in Gabon
S Borrmann et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Chlorproguanil-dapsone versus sulfadoxine-pyrimethamine for sequential episodes of uncomplicated falciparum malaria in Kenya and Malawi: a randomised clinical trial
J Sulo et al.
LANCET (2002)
Oral artesunate dose-response relationship in acute falciparum malaria
BJ Angus et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Chlorproguanil-dapsone (LAPDAP) for uncomplicated falciparum malaria
P Winstanley
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2001)
Molecular evidence of greater selective pressure for drug resistance exerted by the long-acting antifolate pyrimethaminel/sulfadoxine compared with the shorter-acting chlorproguanil/dapsone on Kenyan Plasmodium falciparum
AM Nzila et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Artemether-lumefantrine for the treatment of multidrug-resistant falciparum malaria
M van Vugt et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2000)
Share Paper
